SereNeuro Therapeutics unveiled new data today on a novel approach to chronic pain management and joint tissue preservation. (IMAGE)
Caption
A fluorescence microscopy image displays iPSC-derived peripheral pain-sensing neurons (nociceptors) stained for TUJ1 (cyan) and TRKA (magenta). The cells, which form the basis of SereNeuro’s SN101 therapy function as a "pain sponge" to sequester inflammatory pain factors and halt cartilage degeneration.
Credit
SereNeuro Therapeutics
Usage Restrictions
Credit must be given to the creator. Adaptations must be shared under the same terms.
License
CC BY-SA